{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:03:46Z","timestamp":1790903026193,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,8,15]],"date-time":"2013-08-15T00:00:00Z","timestamp":1376524800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1038\/hr.2013.80","type":"journal-article","created":{"date-parts":[[2013,8,15]],"date-time":"2013-08-15T05:56:34Z","timestamp":1376546194000},"page":"69-75","source":"Crossref","is-referenced-by-count":203,"title":["Nifedipine controlled-release 40\u2009mg b.i.d. in Japanese patients with essential hypertension who responded insufficiently to nifedipine controlled-release 40\u2009mg q.d.: a phase III, randomized, double-blind and parallel-group study"],"prefix":"10.1038","volume":"37","author":[{"given":"Kazuaki","family":"Shimamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Hasebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadayoshi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuomi","family":"Kario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenjiro","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuaki","family":"Dohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhei","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Rakugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatsugu","family":"Horiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Ohya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,15]]},"reference":[{"key":"BFhr201380_CR1","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1161\/01.HYP.0000152079.04553.2c","volume":"45","author":"M Kikuya","year":"2005","unstructured":"Kikuya M, Ohkubo T, Asayama K, Metoki H, Obara T, Saito S, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y . Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality: the Ohasama study. Hypertension 2005; 45: 240\u2013245.","journal-title":"Hypertension"},{"key":"BFhr201380_CR2","first-page":"1462","volume":"28","author":"G Mancia","year":"2007","unstructured":"Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Kjeldsen SE, Erdine S, Narkiewicz K, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Cifkova R, Dominiczak A, Fagard R, Heagerty AM, Laurent S, Lindholm LH, Mancia G, Manolis A, Nilsson PM, Redon J, Schmieder RE, Struijker-Boudier HA, Viigimaa M, Filippatos G, Adamopoulos S, Agabiti-Rosei E, Ambrosioni E, Bertomeu V, Clement D, Erdine S, Farsang C, Gaita D, Kiowski W, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O'Brien E, Ponikowski P, Redon J, Ruschitzka F, Tamargo J, van Zwieten P, Viigimaa M, Waeber B, Williams B, Zamorano JL,, The task force for the management of arterial hypertension of the European Society of Hypertension, The task force for the management of arterial hypertension of the European Society of Cardiology. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007; 28: 1462\u20131536.","journal-title":"Eur Heart J"},{"key":"BFhr201380_CR3","first-page":"3","volume":"32","author":"T Ogihara","year":"2009","unstructured":"Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ito S, Iwao H, Kario K, Kawano Y, Kim-Mitsuyama S, Kimura G, Matsubara H, Matsuura H, Naruse M, Saito I, Shimada K, Shimamoto K, Suzuki H, Takishita S, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Ueshima H, Umemura S, Ishimitsu T, Rakugi H, Japanese Society of Hypertension Committee. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 2009; 32: 3\u2013107.","journal-title":"Hypertens Res"},{"key":"BFhr201380_CR4","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","volume":"42","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ,, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206\u20131252.","journal-title":"Hypertension"},{"key":"BFhr201380_CR5","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1097\/00004872-200311000-00002","volume":"21","author":"JA, Whitworth","year":"2003","unstructured":"Whitworth JA,, World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)\/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21: 1983\u20131992.","journal-title":"J Hypertens"},{"key":"BFhr201380_CR6","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1291\/hypres.27.755","volume":"27","author":"T Ohkubo","year":"2004","unstructured":"Ohkubo T, Obara T, Funahashi J, Kikuya M, Asayama K, Metoki H, Oikawa T, Takahashi H, Hashimoto J, Totsune K, Imai Y,, J-HOME Study Group. Control of blood pressure as measured at home and office, and comparison with physicians' assessment of control among treated hypertensive patients in Japan: First Report of the Japan Home versus Office Blood Pressure Measurement Evaluation (J-HOME) study. Hypertens Res 2004; 27: 755\u2013763.","journal-title":"Hypertens Res"},{"key":"BFhr201380_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3109\/10641963.2012.732640","volume":"35","author":"T Obara","year":"2013","unstructured":"Obara T, Ohkubo T, Ishikura K, Shibamiya T, Ikeda U, Metoki H, Kikuya M, Mano N, Kuriyama S, Imai Y,, J-HOME study group, J-HOME-Morning study group. Change of the management of treated hypertensive patients with or without diabetes in Japan. Clin Exp Hypertens 2013; 35: 79\u201386.","journal-title":"Clin Exp Hypertens"},{"key":"BFhr201380_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1272\/jnms.79.69","volume":"79","author":"N Hatori","year":"2012","unstructured":"Hatori N, Sato K, Miyakawa M, Mitani K, Miyajima M, Yuasa S, Furuki T, Matsuba I, Naka K . The current status of blood pressure control among patients with hypertension: a survey of actual clinical practice. J Nippon Med Sch 2012; 79: 69\u201378.","journal-title":"J Nippon Med Sch"},{"key":"BFhr201380_CR9","doi-asserted-by":"publisher","first-page":"182","DOI":"10.2165\/00003495-198530030-00002","volume":"30","author":"EM Sorkin","year":"1985","unstructured":"Sorkin EM, Clissold SP, Brogden RN . Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders. Drugs 1985; 30: 182\u2013274.","journal-title":"Drugs"},{"key":"BFhr201380_CR10","unstructured":"Bayer plc. Adalat 10 mg soft capsules: summary of product characteristics [online] \n                    http:\/\/www.medicines.org.uk\/emc\/medicine\/20901\n                    \n                   . Accessed 2012 Nov 12."},{"key":"BFhr201380_CR11","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2165\/00003495-200666040-00007","volume":"66","author":"KF Croom","year":"2006","unstructured":"Croom KF, Wellington K . Modified-release nifedipine: a review of the use of modified-release formulations in the treatment of hypertension and angina pectoris. Drugs 2006; 66: 497\u2013528.","journal-title":"Drugs"},{"key":"BFhr201380_CR12","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/j.1365-2125.2003.02056.x","volume":"57","author":"J Minami","year":"2004","unstructured":"Minami J, Numabe A, Andoh N, Kobayashi N, Horinaka S, Ishimitsu T, Matsuoka H . Comparison of once-daily nifedipine controlled-release with twice-daily nifedipine retard in the treatment of essential hypertension. Br J Clin Pharmacol 2004; 57: 632\u2013639.","journal-title":"Br J Clin Pharmacol"},{"key":"BFhr201380_CR13","first-page":"s241","volume":"23","author":"N Nakamichi","year":"1995","unstructured":"Nakamichi N, Yanagida T, Hikima Y . A phase I clinical trial of nifedipine controlled-release formulation (BAY a 1040-OD tablet): a single-dose study [in Japanese]. Jpn Pharmacol Ther 1995; 23: s241\u2013s255.","journal-title":"Jpn Pharmacol Ther"},{"key":"BFhr201380_CR14","first-page":"s257","volume":"23","author":"N Nakamichi","year":"1995","unstructured":"Nakamichi N, Yanagida T, Hikima Y . A phase I clinical trial of nifedipine controlled-release formulation (BAY a 1040-OD tablet): a repeated-dose study [in Japanese]. Jpn Pharmacol Ther 1995; 23: s257\u2013s269.","journal-title":"Jpn Pharmacol Ther"},{"key":"BFhr201380_CR15","first-page":"232","volume":"30","author":"T Tanaka","year":"2013","unstructured":"Tanaka T, Yoshikawa K, Nagasawa T, Uemura M, Okumura K, Kajikawa M, Tajiri M, Liu Y . Investigation on the anti-hypertensive effect and plasma nifedipine concentration profile after 80mg\/day treatment with Adalat CR in the uncontrolled essential hypertension patients treated with 40mg\/day treatment [in Japanese]. Jpn J TDM 2013; 30: 232.","journal-title":"Jpn J TDM"},{"key":"BFhr201380_CR16","first-page":"1869","volume":"25","author":"M Ishii","year":"1997","unstructured":"Ishii M . Clinical evaluation on montherapy of BAY a 1040-OD tablets (nifedipine sustained-release formulation) in patients with essential hypertension: double-blind, comparative study with nifedipine retard tablets (Adalat Rm L) (revised report) [in Japanese]. Jpn Pharmacol Ther 1997; 25: 1869\u20131902.","journal-title":"Jpn Pharmacol Ther"},{"key":"BFhr201380_CR17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3109\/10641963.2011.601377","volume":"34","author":"N Kobayashi","year":"2012","unstructured":"Kobayashi N, Ishimitsu T . Assessment on antihypertensive effect and safety of nifedipine controlled-release tablet administered at 80 mg\/day in practical clinic. Clin Exp Hypertens 2012; 34: 191\u2013200.","journal-title":"Clin Exp Hypertens"},{"key":"BFhr201380_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/00005344-198501000-00003","volume":"7","author":"K Landmark","year":"1985","unstructured":"Landmark K . Antihypertensive and metabolic effects of long-term therapy with nifedipine slow-release tablets. J Cardiovasc Pharmacol 1985; 7: 12\u201317.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BFhr201380_CR19","doi-asserted-by":"publisher","first-page":"S298","DOI":"10.1097\/00005344-198200433-00008","volume":"4","author":"K Aoki","year":"1982","unstructured":"Aoki K, Kawaguchi Y, Sato K, Kondo S, Yamamoto M . Clinical and pharmacological properties of calcium antagonists in essential hypertension in humans and spontaneously hypertensive rats. J Cardiovasc Pharmacol 1982; 4: S298\u2013S302.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BFhr201380_CR20","unstructured":"Bayer plc. Adalat LA 20, 30 and 60; summary of product characteristics (UK) \n                    http:\/\/www.emc.medicines.org.uk\n                    \n                   Accessed 2012 Nov 12."},{"key":"BFhr201380_CR21","unstructured":"Bayer plc. Adalat retard: summary of product characteristics (UK) \n                    http:\/\/www.emc.medicines.org.uk\n                    \n                   . Accessed 2012 Nov 12."},{"key":"BFhr201380_CR22","unstructured":"Bayer Yakuhin Ltd. Adalat-CR10mg\/20mg\/40mg (nifedipine): prescribing information (Japan) \n                    http:\/\/www.jpma.or.jp\n                    \n                   Accessed 2012 Nov 12."},{"key":"BFhr201380_CR23","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/jhh.2008.161","volume":"23","author":"T Fujiwara","year":"2009","unstructured":"Fujiwara T, Ii Y, Hatsuzawa J, Murase H, Watanabe T, Murakami M, Kimura N, Buch J, Tsuchihashi T, Saruta T . The Phase III, double-blind, parallel-group controlled study of amlodipine 10 mg once daily in Japanese patients with essential hypertension who insufficiently responded to amlodipine 5 mg once daily. J Hum Hypertens 2009; 23: 521\u2013529.","journal-title":"J Hum Hypertens"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/hr201380.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr201380","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr201380.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:13:12Z","timestamp":1684429992000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hr201380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,15]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["BFhr201380"],"URL":"https:\/\/doi.org\/10.1038\/hr.2013.80","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,15]]}}}